← Open Payments lookup

THERESA ENGLUTT: Open Payments

NPI 1083355911 · DENISON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,206 in 199 payments from 28 companies in 2025. Trend: 2023 $1,185 · 2024 $2,494 · 2025 $6,206

Food & beverage: $4,039Consulting: $1,880Travel & lodging: $286
CompanyPaymentsAmount
GENZYME CORPORATION23$2,569
GlaxoSmithKline, LLC.42$475
AstraZeneca Pharmaceuticals LP15$422
AOP Health US, LLC1$342
Avadel CNS Pharmaceuticals, LLC5$281
Regeneron Healthcare Solutions, Inc.10$247
Takeda Pharmaceuticals U.S.A., Inc.19$231
Viatris Specialty LLC11$189
Actelion Pharmaceuticals US, Inc.4$178
Axsome Therapeutics, Inc.11$170

Products named: DUPIXENT, Rapiblyk, LUMRYZ, NUCALA, TRELEGY ELLIPTA, BREZTRI, GLASSIA, YUPELRI.

Industry payments across TX — which companies pay providers there.